Swiss Group for Clinical Cancer Research
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1965-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sakk.ch/
Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2003-09-24
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 240
- Registration Number
- NCT00003280
- Locations
- 🇨🇭
Istituto Oncologico della Svizzera Italiana, Lugano, Switzerland
🇨🇭City Hospital Triemli, Zurich, Switzerland
🇨🇭Hopital Cantonal Universitaire de Geneva, Geneva, Switzerland
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
- First Posted Date
- 2003-07-01
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 5
- Registration Number
- NCT00031889
- Locations
- 🇨🇭
Inselspital, Bern, Bern, Switzerland
🇨🇭Spitalzentrum Biel, Biel, Switzerland
🇨🇭Ospedale Beata Vergine, Mendrisio, Switzerland
Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2003-06-25
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 75
- Registration Number
- NCT00030797
- Locations
- 🇨🇭
Inselspital, Bern, Bern, Switzerland
Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy
- Conditions
- Leukemia
- First Posted Date
- 2003-04-30
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 25
- Registration Number
- NCT00003757
- Locations
- 🇨🇭
Klinik Hirslanden, Zurich, Switzerland
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
- Conditions
- Breast Cancer
- Interventions
- Drug: Herceptin™ (Her)Drug: Herceptin™ (Her) + chemo
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 175
- Registration Number
- NCT00004935
- Locations
- 🇮🇹
Ospedale di Circolo e Fondazione Macchi, Varese, Italy
🇨🇭Regionalspital, Thun, Switzerland
🇨🇭Kantonsspital Graubuenden, Chur, Switzerland
Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC
- Conditions
- Lung Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 46
- Registration Number
- NCT00030810
- Locations
- 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
- Conditions
- Gastric Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Registration Number
- NCT00004873
- Locations
- 🇨🇭
Hopital Cantonal Universitaire de Geneva, Geneva, Switzerland
Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 34
- Registration Number
- NCT00031876
- Locations
- 🇨🇭
Inselspital, Bern, Bern, Switzerland
🇨🇭UniversitaetsSpital, Zurich, Switzerland
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
- Conditions
- Gastric Cancer
- Interventions
- Drug: Immediate surgeryDrug: Taxotere-Cisplatin-5FU
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 240
- Registration Number
- NCT00005060
- Locations
- 🇨🇭
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
🇨🇭Zentrum fuer Tumordiagnostikund Praevention, St. Gallen, Switzerland
🇮🇹European Institute of Oncology, Milan, Italy
Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Swiss Group for Clinical Cancer Research
- Target Recruit Count
- 110
- Registration Number
- NCT00003902
- Locations
- 🇨🇭
Kantonsspital - St. Gallen, St. Gallen, Switzerland